search
Back to results

Fish Oil vs. Placebo on Subjective Effects of Alcohol

Primary Purpose

Alcohol Dependence

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Fish Oil with ethanol and placebo ethanol infusions
Placebo with ethanol and placebo ethanol infusions
Sponsored by
Yale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Alcohol Dependence focused on measuring Alcohol Dependence, Fish Oil

Eligibility Criteria

21 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Male and females, between the ages of 21 and 55;
  2. No current drug use disorder of any drugs of abuse (except tobacco or marijuana);
  3. No current medical problems and normal ECG;
  4. For women, not pregnant as determined by pregnancy screening nor breast feeding, and using acceptable birth control methods.

Exclusion Criteria:

  1. Current major psychiatric illnesses including mood, psychotic, or anxiety disorders;
  2. History of major medical illnesses; including liver diseases, heart disease, chronic pain or other medical conditions that the physician investigator deems contraindicated for the subject to be in the study;
  3. Liver function tests (ALT or AST) greater than 3 times normal;
  4. Allergy to seafood.

Sites / Locations

  • VA Connecticut Healtcare System

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Fish Oil with ethanol and placebo ethanol infusions

Placebo with ethanol and placebo ethanol infusions

Arm Description

Between days 30-40 subjects will participate in 2 test days at least 2 days apart and during the test day will receive an IV infusion of ethanol (placebo vs. targeted Breath Alcohol Concentration ((BrAC) of 100mg%) in a clamped fashion. Test days will be in a randomized order.

Between days 30-40 subjects will participate in 2 test days at least 2 days apart and during the test day will receive an IV infusion of ethanol (placebo vs. targeted Breath Alcohol Concentration ((BrAC) of 100mg%) in a clamped fashion. Test days will be in a randomized order.

Outcomes

Primary Outcome Measures

Assessment of stimulant and sedative effects of alcohol with the Biphasic Alcohol Effects Scale (BAES).
The BAES is a 14-item self-report scale. Seven items measure stimulant effects of alcohol during the test sessions and seven items measure sedative effects. Stimulant and sedative effect scores range from 0 (not at all) to 70 (extremely).
Assessment of stimulant and sedative effects of alcohol with the Biphasic Alcohol Effects Scale (BAES).
Assessment of stimulant and sedative effects of alcohol with the Biphasic Alcohol Effects Scale (BAES).

Secondary Outcome Measures

Cognitive performance measured with the Rapid Information Processing Task (RVIP)
(RVIP) is a widely used task to assess sustained attention, with a working memory component. In this task, a series of single digits is presented on a computer screen at a rate of 100 digits per minute for 4 min. Targets are defined as three consecutive odd digits (e.g., 7-9-3) or three consecutive even digits (e.g., 2-8-6). The percentage of targets correctly detected will be the main outcome measure.
Cognitive performance measured with the Rapid Information Processing Task (RVIP)
(RVIP) is a widely used task to assess sustained attention, with a working memory component. In this task, a series of single digits is presented on a computer screen at a rate of 100 digits per minute for 4 min. Targets are defined as three consecutive odd digits (e.g., 7-9-3) or three consecutive even digits (e.g., 2-8-6). The percentage of targets correctly detected will be the main outcome measure.
Cognitive performance measured with the Rapid Information Processing Task (RVIP)
(RVIP) is a widely used task to assess sustained attention, with a working memory component. In this task, a series of single digits is presented on a computer screen at a rate of 100 digits per minute for 4 min. Targets are defined as three consecutive odd digits (e.g., 7-9-3) or three consecutive even digits (e.g., 2-8-6). The percentage of targets correctly detected will be the main outcome measure.
Cognitive performance measured by a "Go No-Go task" will assess the ability to withhold responses to an infrequently occurring target.
A series of blue and green rectangular shapes are presented every 1150 ms and participants are instructed to press a spacebar every time the green rectangular shape appeared, and to give equal importance to speed and accuracy. The primary outcome is the number of errors on the No-Go trials.
Cognitive performance measured by a "Go No-Go task" will assess the ability to withhold responses to an infrequently occurring target.
A series of blue and green rectangular shapes are presented every 1150 ms and participants are instructed to press a spacebar every time the green rectangular shape appeared, and to give equal importance to speed and accuracy. The primary outcome is the number of errors on the No-Go trials.
Cognitive performance measured by a "Go No-Go task" will assess the ability to withhold responses to an infrequently occurring target.
A series of blue and green rectangular shapes are presented every 1150 ms and participants are instructed to press a spacebar every time the green rectangular shape appeared, and to give equal importance to speed and accuracy. The primary outcome is the number of errors on the No-Go trials.
Cognitive performance measured by the Hopkins Verbal Learning Test-Revised (HVLT-R).
The HVLT-R is a word list learning test of verbal memory. The outcome is the percent correct on immediate and delayed recall of words on a list.
Cognitive performance measured by the Hopkins Verbal Learning Test-Revised (HVLT-R).
The HVLT-R is a word list learning test of verbal memory. The outcome is the percent correct on immediate and delayed recall of words on a list.
Cognitive performance measured by the Hopkins Verbal Learning Test-Revised (HVLT-R).
The HVLT-R is a word list learning test of verbal memory. The outcome is the percent correct on immediate and delayed recall of words on a list.
Motor Impairment: The Grooved Pegboard Test (Lafayette Instrument Company) is a manipulative dexterity test,
This is an eye-to hand timed coordination test. A quicker time indicates greater coordination.
Motor Impairment: The Grooved Pegboard Test (Lafayette Instrument Company) is a manipulative dexterity test,
This is an eye-to hand timed coordination test. A quicker time indicates greater coordination.
Motor Impairment: The Grooved Pegboard Test (Lafayette Instrument Company) is a manipulative dexterity test,
This is an eye-to hand timed coordination test. A quicker time indicates greater coordination.

Full Information

First Posted
December 15, 2016
Last Updated
September 20, 2022
Sponsor
Yale University
Collaborators
VA Connecticut Healthcare System
search

1. Study Identification

Unique Protocol Identification Number
NCT03010917
Brief Title
Fish Oil vs. Placebo on Subjective Effects of Alcohol
Official Title
Effect of Fish Oil vs. Placebo on Subjective Effects of Alcohol in Healthy Humans
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
March 2, 2017 (Actual)
Primary Completion Date
May 30, 2021 (Actual)
Study Completion Date
September 8, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University
Collaborators
VA Connecticut Healthcare System

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This project represents a first step in examining the potential use of fish oil for the treatment of alcohol use disorder (AUD). The investigators will be testing for attenuation of alcohol-induced sedative and stimulant effects, as well as cognitive effects and cerebellar effects in healthy social drinkers.
Detailed Description
There have been no studies to date that have examined the relationship between fish oil and alcohol response in humans. The current study was designed to examine the relationship between fish oil and subjective alcohol effects in healthy social drinkers. This project represents a first step in examining the potential use of fish oil for the treatment of alcohol use disorder (AUD). The investigators will evaluate responses to alcohol through administration of a steady state blood alcohol level (BAL) with an IV infusion using a method that employs an infusion that is titrated to a breathalyzer reading and clamped at a steady state. This approach allows direct comparisons of the acute effects of a specific dose of ethanol between groups, without the confounding factors of variable alcohol absorption and peak BAL's. This approach will allow the examiners to carefully examine if fish oil changes the acute effects of alcohol on a number of outcome domains including subjective drug effects, cognitive performance, and cerebellar effects. As this study is a pilot study, it is not clear whether fish oil will attenuate alcohol induced subjective stimulation or sedation. Since this is the first study to evaluate fish oil's effects on alcohol-effects in the laboratory, the investigators will be testing for attenuation of alcohol-induced sedative and stimulant effects, as well as cognitive effects and cerebellar effects. In this study, fish oil will be administered at 3 grams/day for 30-40 days (3 capsules twice a day). The investigators will use 3 grams/day for two reasons: 1) it is within the range of doses safely used in humans (1g to 6g) as a treatment for various psychiatric conditions (depression, anxiety, borderline personality disorder), and 2) is a dose that has shown efficacy in various clinical trials for psychiatric conditions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alcohol Dependence
Keywords
Alcohol Dependence, Fish Oil

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Crossover Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
17 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Fish Oil with ethanol and placebo ethanol infusions
Arm Type
Experimental
Arm Description
Between days 30-40 subjects will participate in 2 test days at least 2 days apart and during the test day will receive an IV infusion of ethanol (placebo vs. targeted Breath Alcohol Concentration ((BrAC) of 100mg%) in a clamped fashion. Test days will be in a randomized order.
Arm Title
Placebo with ethanol and placebo ethanol infusions
Arm Type
Placebo Comparator
Arm Description
Between days 30-40 subjects will participate in 2 test days at least 2 days apart and during the test day will receive an IV infusion of ethanol (placebo vs. targeted Breath Alcohol Concentration ((BrAC) of 100mg%) in a clamped fashion. Test days will be in a randomized order.
Intervention Type
Drug
Intervention Name(s)
Fish Oil with ethanol and placebo ethanol infusions
Intervention Description
Fish Oil with ethanol and placebo ethanol infusions
Intervention Type
Drug
Intervention Name(s)
Placebo with ethanol and placebo ethanol infusions
Intervention Description
Placebo with ethanol and placebo ethanol infusions
Primary Outcome Measure Information:
Title
Assessment of stimulant and sedative effects of alcohol with the Biphasic Alcohol Effects Scale (BAES).
Description
The BAES is a 14-item self-report scale. Seven items measure stimulant effects of alcohol during the test sessions and seven items measure sedative effects. Stimulant and sedative effect scores range from 0 (not at all) to 70 (extremely).
Time Frame
Baseline
Title
Assessment of stimulant and sedative effects of alcohol with the Biphasic Alcohol Effects Scale (BAES).
Time Frame
Week 4 (test session 1)
Title
Assessment of stimulant and sedative effects of alcohol with the Biphasic Alcohol Effects Scale (BAES).
Time Frame
Week 6 (test session 2)
Secondary Outcome Measure Information:
Title
Cognitive performance measured with the Rapid Information Processing Task (RVIP)
Description
(RVIP) is a widely used task to assess sustained attention, with a working memory component. In this task, a series of single digits is presented on a computer screen at a rate of 100 digits per minute for 4 min. Targets are defined as three consecutive odd digits (e.g., 7-9-3) or three consecutive even digits (e.g., 2-8-6). The percentage of targets correctly detected will be the main outcome measure.
Time Frame
Baseline
Title
Cognitive performance measured with the Rapid Information Processing Task (RVIP)
Description
(RVIP) is a widely used task to assess sustained attention, with a working memory component. In this task, a series of single digits is presented on a computer screen at a rate of 100 digits per minute for 4 min. Targets are defined as three consecutive odd digits (e.g., 7-9-3) or three consecutive even digits (e.g., 2-8-6). The percentage of targets correctly detected will be the main outcome measure.
Time Frame
Week 4 (test session 1)
Title
Cognitive performance measured with the Rapid Information Processing Task (RVIP)
Description
(RVIP) is a widely used task to assess sustained attention, with a working memory component. In this task, a series of single digits is presented on a computer screen at a rate of 100 digits per minute for 4 min. Targets are defined as three consecutive odd digits (e.g., 7-9-3) or three consecutive even digits (e.g., 2-8-6). The percentage of targets correctly detected will be the main outcome measure.
Time Frame
Week 6 (test session 2)
Title
Cognitive performance measured by a "Go No-Go task" will assess the ability to withhold responses to an infrequently occurring target.
Description
A series of blue and green rectangular shapes are presented every 1150 ms and participants are instructed to press a spacebar every time the green rectangular shape appeared, and to give equal importance to speed and accuracy. The primary outcome is the number of errors on the No-Go trials.
Time Frame
Baseline
Title
Cognitive performance measured by a "Go No-Go task" will assess the ability to withhold responses to an infrequently occurring target.
Description
A series of blue and green rectangular shapes are presented every 1150 ms and participants are instructed to press a spacebar every time the green rectangular shape appeared, and to give equal importance to speed and accuracy. The primary outcome is the number of errors on the No-Go trials.
Time Frame
Week 4 (test session 1)
Title
Cognitive performance measured by a "Go No-Go task" will assess the ability to withhold responses to an infrequently occurring target.
Description
A series of blue and green rectangular shapes are presented every 1150 ms and participants are instructed to press a spacebar every time the green rectangular shape appeared, and to give equal importance to speed and accuracy. The primary outcome is the number of errors on the No-Go trials.
Time Frame
Week 6 (test session 2)
Title
Cognitive performance measured by the Hopkins Verbal Learning Test-Revised (HVLT-R).
Description
The HVLT-R is a word list learning test of verbal memory. The outcome is the percent correct on immediate and delayed recall of words on a list.
Time Frame
Baseline
Title
Cognitive performance measured by the Hopkins Verbal Learning Test-Revised (HVLT-R).
Description
The HVLT-R is a word list learning test of verbal memory. The outcome is the percent correct on immediate and delayed recall of words on a list.
Time Frame
Week 4 (test session 1)
Title
Cognitive performance measured by the Hopkins Verbal Learning Test-Revised (HVLT-R).
Description
The HVLT-R is a word list learning test of verbal memory. The outcome is the percent correct on immediate and delayed recall of words on a list.
Time Frame
Week 6 (test session 2)
Title
Motor Impairment: The Grooved Pegboard Test (Lafayette Instrument Company) is a manipulative dexterity test,
Description
This is an eye-to hand timed coordination test. A quicker time indicates greater coordination.
Time Frame
Baseline
Title
Motor Impairment: The Grooved Pegboard Test (Lafayette Instrument Company) is a manipulative dexterity test,
Description
This is an eye-to hand timed coordination test. A quicker time indicates greater coordination.
Time Frame
Week 4 (test session 1)
Title
Motor Impairment: The Grooved Pegboard Test (Lafayette Instrument Company) is a manipulative dexterity test,
Description
This is an eye-to hand timed coordination test. A quicker time indicates greater coordination.
Time Frame
Week 6 (test session 2)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male and females, between the ages of 21 and 55; No current drug use disorder of any drugs of abuse (except tobacco or marijuana); No current medical problems and normal ECG; For women, not pregnant as determined by pregnancy screening nor breast feeding, and using acceptable birth control methods. Exclusion Criteria: Current major psychiatric illnesses including mood, psychotic, or anxiety disorders; History of major medical illnesses; including liver diseases, heart disease, chronic pain or other medical conditions that the physician investigator deems contraindicated for the subject to be in the study; Liver function tests (ALT or AST) greater than 3 times normal; Allergy to seafood.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ismene Petrakis, M.D.
Organizational Affiliation
Yale University/VA Connecticut Healthcare System
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Connecticut Healtcare System
City
West Haven
State/Province
Connecticut
ZIP/Postal Code
06516
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
12394280
Citation
Subramanian MG, Heil SH, Kruger ML, Collins KL, Buck PO, Zawacki T, Abbey A, Sokol RJ, Diamond MP. A three-stage alcohol clamp procedure in human subjects. Alcohol Clin Exp Res. 2002 Oct;26(10):1479-83. doi: 10.1097/01.ALC.0000034038.41972.36.
Results Reference
background
PubMed Identifier
21792747
Citation
Zimmermann US, O'Connor S, Ramchandani VA. Modeling alcohol self-administration in the human laboratory. Curr Top Behav Neurosci. 2013;13:315-53. doi: 10.1007/7854_2011_149.
Results Reference
background
PubMed Identifier
10470974
Citation
Ramchandani VA, O'Connor S, Blekher T, Kareken D, Morzorati S, Nurnberger J Jr, Li TK. A preliminary study of acute responses to clamped alcohol concentration and family history of alcoholism. Alcohol Clin Exp Res. 1999 Aug;23(8):1320-30.
Results Reference
background

Learn more about this trial

Fish Oil vs. Placebo on Subjective Effects of Alcohol

We'll reach out to this number within 24 hrs